Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
-.--%-.--%-8.31x3.87x3.62x-6.69x-6.28x 2.07B
0.62%0.7%16.36x1.9x3.55x9.58x10.48x 64.28B
0.56%0.57%28.32x4.27x5.77x16.88x21.02x 57.29B
-.--%-.--%35.89x7.21x12.16x23.03x27.05x 43.45B
3.59%3.68%-56.58x2.33x3.05x9x10.5x 38.02B
-.--%-.--%34.98x1.72x3.72x11.41x13.28x 31.98B
-.--%-.--%-8.06x4.75x11.55x-7.04x-6.67x 27.66B
-.--%-.--%16.64x3.33x3.17x9.59x9.5x 22.91B
-.--%0.06%50.41x5.1x5.55x38.45x35.52x 17.74B
-.--%-.--%25.58x3.64x5.32x14.26x19.77x 16.45B
-.--%-.--%-33.1x-5.74x15.4x-46.83x-48.67x 14.1B
0.14%0.14%68.24x27.83x41.56x58.77x60.62x 12.95B
-.--%-.--%-122.33x12771.19x12.48x-110.56x-121.48x 12.41B
-.--%-.--%49.05x - - - - 11.15B
-.--%-.--%16.37x - 3.5x12.84x15.39x 11.15B
2.84%3.28%11.84x1.03x1.81x7.31x9.79x 6.27B
1.64%1.82%13.68x1.26x2.38x6.24x7.46x 5.51B
-.--%-.--%-103.64x - - - - 5.07B
Average 0.52% 0.57% 1.96x 855.58x 8.41x 2.89x 3.58x 22.25B
Weighted average by Cap. 0.59% 0.63% 9.76x 428.72x 7.50x 8.25x 9.68x
Biopharmaceuticals